Cameron Urges Lighter Regulation to Speed New Drug Development
This article is for subscribers only.
U.K. Prime Minister David Cameron will push for lighter regulations on the pharmaceutical industry in order to speed the path of new medicines to the market.
Cameron, who is in Washington to meet with President Barack Obama, sees the current process of developing and licensing new drugs as “abhorrently expensive and time consuming,” according to a statement from his office.